Participation of kynurenine pathway metabolites in Trypanosoma cruzi infection of human placenta
Placenta · 2026-10 · 184 · 57-65
DOI: 10.1016/j.placenta.2025.09.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2026-10. Verfasst von María José Moreira-Espinoza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biología Celular. Cátedra de Biología Celular, Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba. …. Hauptthemen laut MEDLINE: Kynurenine, Placenta, Chagas Disease, Trypanosoma cruzi. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Fund for Scientific and Technological Research, National University of Villa Maria.
Abstract (Originalsprache)
INTRODUCTION: The kynurenine pathway is a major route of tryptophan (Trp) metabolism, an essential amino acid. This pathway, mediated by Indoleamine 2,3-dioxygenase (IDO), contributes to maternal-fetal tolerance by depletion Trp and generating kynurenines (Kyn). Among the Kyns produced in the placenta, 3-hydroxykynurenine (3-HK) and 3-hydroxy-anthranilic acid (3-HAA) have been shown to affect T. cruzi replication. This study aimed to evaluate the role of kynurenine pathway metabolites in Trypanosoma cruzi (T. cruzi) infection of the human placenta. METHODS: Term human placental explants (n = 8) were infected with 105 T. cruzi trypomastigotes/mL for 24 h. The explants were treated with L-Trp, L-1-methyl-tryptophan (L-1MT), IFN-γ, 3-HK and 3-HAA for 72 or 96 hpi. IDO expression was assessed by immunohistochemistry, and IDO activity was measured in homogenates. L-Kyn concentration was quantified in culture supernatants, while infection levels were determined by qPCR. Statistical analysis included ANOVA with Tukey's post hoc test and Student's t-test (p < 0.05). RESULTS: L-Trp increased IDO expression and activity, elevating L-Kyn production in both infected and non-infected explants. L-1MT reduced L-Kyn production, whereas IFN-γ stimulated it. Additionally, 3-HK significantly impaired trypomastigotes motility. Both 3-HK and 3-HAA decreased placenta explant infection by T. cruzi. CONCLUSION: Metabolites of the kynurenine pathways reduced T. cruzi infection in placental explants, suggesting a potential role in limiting congenital transmission of Chagas disease by modulating parasitic load in human placenta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Biología Celular. Cátedra de Biología Celular, Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba. Bv. de La Reforma y Enfermera Gordillo. s/n. Ciudad Universitaria, Cór…
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba. Haya de la Torre y M. Allende s/n, Ciud…
Förderung
- Fund for Scientific and Technological Research
- National University of Villa Maria
Zitieren
APA
Moreira-Espinoza, M. J., Mezzano, L., Theumer, M. G., Panzetta-Dutari, G. M., Triquell, M. F., Díaz-Luján, C. M., & Fretes, R. E. (2026). Participation of kynurenine pathway metabolites in Trypanosoma cruzi infection of human placenta. Placenta, 184, 57-65. https://doi.org/10.1016/j.placenta.2025.09.008
Vancouver
Moreira-Espinoza MJ, Mezzano L, Theumer MG, Panzetta-Dutari GM, Triquell MF, Díaz-Luján CM, et al. Participation of kynurenine pathway metabolites in Trypanosoma cruzi infection of human placenta. Placenta. 2026;184:57-65. doi:10.1016/j.placenta.2025.09.008
BibTeX
@article{MoreiraEspinoza2026,
author = {Moreira-Espinoza, María José and Mezzano, Luciana and Theumer, Martin G and Panzetta-Dutari, Graciela María and Triquell, María Fernanda and Díaz-Luján, Cintia María and Fretes, Ricardo E},
title = {Participation of kynurenine pathway metabolites in Trypanosoma cruzi infection of human placenta},
journal = {Placenta},
year = {2026},
volume = {184},
pages = {57--65},
doi = {10.1016/j.placenta.2025.09.008}
}
EUVIMED